2019 | New York Transcatheter Valves Symposium

Alcohol Septal Ablation for HOCM: Case Selection

71

0:14:59

TPVR Devices: Update

65

0:10:12

Trials of Tricuspid Valve Technology in 2020: Where are we Now?

56

0:14:16

TMVR Technologies vs. Surgical Therapies for Mitral Regurgitation

38

0:10:22

Novel TMVR Technologies: View of the Future

53

0:13:13

Current and Future Trials of Transcatheter Mitral Valve Replacement

59

0:12:05

Future of MitraClip Post COAPT Trial

95

0:10:54

Key Points in Imaging for Transcatheter Valve Therapy

38

0:11:05

Minimalistic TAVR: Early Discharge and Pacing Algorithm

30

0:10:50

Alternate Vascular Access of TAVR

48

0:8:36

Managing Complications of TAVR

94

0:10:53

Adjunctive Pharmacotherapy During TAVR: Update

37

0:12:49

TAVR in Bicuspid AS: Standard of Care or Do We Need a Randomized Trial?

36

0:12:28

New Next Generation TAVR Technology in 2020+

79

0:11:16

Transcatheter Valve Therapies in Heart Failure: New Perspective in 2020

53

0:21:31

Transcatheter Valve Therapies in 2020: A Surgeon’s Perspective

46

0:21:21

Valvular Heart Disease in 2020: State of the Art

78

0:18:54

Top Ten Advances in Transcatheter Valve Therapy in 2019

89

0:31:51